PR Newswire Consumer Products#press
Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assaystranslating…
Factuality: 72/100UnknownPR Publishing
SEATTLE and RICHMOND, BC, Aug. 26, 2026 /PRNewswire/ -- Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. (SZSE: 301047), today announced a non-exclusive licensing agreement covering…